Kenneth Ng Email & Phone Number

Portland, Or, Us

Stamford, Ct, Us

• Currently managing copy and content development for a start-up market access platform within the established Lockwood medical marketing group• Providing strategic communication insights and action plans for established products in asthma/COPD, mental health, and thyroid eye disease• Developing pre-approval information exchange and payer value proposition materials (field presentations, brochures/leave-behinds, websites) for launch brands in neuro-oncology

Stamford, Ct, Us

• Led content development efforts for 3 pharmaceutical brands (1 in rare eye disease, 1 in COPD, 1 for bipolar/schizophrenia), including the creation of payer value propositions, clinical monographs, payer disease state presentations, and market research materials• Developed preapproval information exchange (PIE) communications for 2 oncology products in glioma and hematological cancers (AML, MDS), highlighting the critical clinical data to key US payer targets• Facilitated high-value, face-to-face engagement between pharma marketers and payer thought-leaders through multiple live and virtual advisory activities across different therapeutic areas

Stamford, Ct, Us

• Led the scientific team for 5 pharmaceutical brands: 3 mature brands in inflammatory disease, 1 mature brand in an ultra-rare immunodeficiency (<1000 patients), and 1 new product in commercial development for a rare, inflammatory disease• Engaged HCPs for virtual advisory activities across live and asynchronous (offline) platforms• Launched virtual peer-to-peer education programs for 4 different brands during COVID-19 shutdown, enabling continued HCP engagement in absence of live speaker events• Stabilized volume and revenue of 3 end-of-lifecycle pharmaceuticals by refocusing existing marketing/education tactics from physicians to advanced practice providers (ie, RN, NP, PAs)• Successfully launched a blockbuster biologic therapy in thyroid eye disease ($800MM FY2020, $1.6BB FY2021), including an intensive “advisory board road show” that delivered launch-critical strategy and insights• Active in new business development, helping to pitch/win 3 accounts ($2.2MM revenue) in FY2019

• Led as an executive leader and Chief Scientific Officer of a startup, market access agency • Identified 7 high-priority business leads, leading to 3 account wins, & $1.2MM revenue in 2016-17• Pitched and won a $2.4 MM oncology portfolio, representing 36% of 2018 company revenue• Created business targeting process within the company, increasing potential client leads by 200%• Drove social media marketing efforts, resulting in a top 10 Google ranking for company website (formerly Choreo Market Access)• Developed data release strategy for mRNA and cancer vaccine start-up that increased client visibility and enabled a successful $100MM+ IPO• Coached vaccine regulatory team to unanimous positive FDA AdComm vote and marketing approval (GSK Shingrix)• Created payer launch campaigns for a novel ADF opioid and a SHPT medication, contributing to broad commercial and Medicare Part D coverage within 6 months of launch (>50% of covered lives each)• Managed value proposition development and deliverables for 3 drugs in chronic lymphocytic leukemia, small-cell lung cancer, and glioblastoma multiforme• Started inter-agency training and blogging initiatives on relevant payer subjects, including FDAMA 114, CFL guidance, co-pay assistance programs, and PBM/SPP channel strategy

New York, Ny, Us

• Invented a patented polymer scaffold for the repair of cartilage lesions (currently in pre-clinical animal trials)• Created drug delivery microparticle and scaffold coating technologies to improve healing from musculoskeletal injuries• Managed teams comprised of orthopedic surgeons, students (medical, graduate, undergraduate), and volunteers (including visiting international Surgeon-in-Chief) to spearhead scientific research projects• Awarded $100,000 from the National Institutes of Health, Bethesda, MD to develop a novel processing method for soft tissues used to reconstruct torn anterior cruciate ligaments

Washington, Dc, Us

• Served on editorial board as Key Opinion Leader for Science Translational Medicine to evaluate breakthroughs in scientific literature and determine journal policy and content• Wrote 19 popular science articles (“Editor’s Choice”) to highlight exciting scientific discoveries and foster improved collaboration/communication between scientists, doctors, and the general public• Article topics: Stem cells, cancer, diabetes, cardiovascular stents, drug delivery, orthopedics, tissue engineering

New York, Ny, Us

• Job functions/research performed jointly with Dr. James L. Cook at the University of Missouri - Columbia• Developed the _first_ engineered canine cartilage constructs with 100% of the native tissue properties for large-animal, tissue engineering trials in a clinically relevant, adult canine model (FDA large animal model)• Collaborated with veterinary surgeons at University of Missouri to develop tissue engineered construct (focal and patella) implantation and retrieval techniques• Awarded a $40,000 industry grant from Integra Life Sciences to determine the failure mechanisms of the Achillon, a novel Achilles tendon repair device (in collaboration with orthopedic surgeons at St. Luke’s – Roosevelt Hospital Center)

New York, Ny, Us

• Developed the _first_ layered scaffold system to fabricate a biomimetic engineered cartilage construct with both prescribed mechanical inhomogeneity and zonal chondrocyte populations• Developed and evaluated strategies for improved mechanical and matrix properties in engineered cartilage: Transient application of anabolic growth factors (TGF-β1, TGF-β3, or IGF-I), increasing amino acid supply, collagen hydrolysate supplementation, controlled scaffold degradation• Co-developed surgical procedures for a novel, in vivo, loading bioreactor utilizing the intervertebral disc (IVD) space of a rat tail• Studied the effects of surgical implantation and loading on the properties of tissue engineered cartilage implanted into the IVD space of a rat tail• Collaborated with the Department of Orthopaedic Surgery, St. Luke’s – Roosevelt Hospital Center, New York, NY to develop an intensive, 2-month, research rotation program for surgical residents• Managed and mentored 6 orthopedic surgical residents and 5 undergraduate students in scientific research

New York, Ny, Us

• Developed website for Administrative Information Services (AIS) utilizing Adobe Flash, Photoshop, and ColdFusion software• Provided IT technical support for networking, desktop systems, and internal and external applications for data management

Master Of Science - Ms, Clinical And Translational Investigation

Doctor Of Philosophy - Phd, Biomedical Engineering

Master Of Philosophy - Mphil, Biomedical Engineering

Master Of Science - Ms, Biomedical Engineering

Bachelor Of Science - Bs, Biomedical Engineering

Education record